Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer.
McKeage MJ, Von Pawel J, Reck M, Jameson MB, Rosenthal MA, Sullivan R, Gibbs D, Mainwaring PN, Serke M, Lafitte JJ, Chouaid C, Freitag L, Quoix E. McKeage MJ, et al. Among authors: lafitte jj. Br J Cancer. 2008 Dec 16;99(12):2006-12. doi: 10.1038/sj.bjc.6604808. Br J Cancer. 2008. PMID: 19078952 Free PMC article. Clinical Trial.
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.
Sculier JP, Lafitte JJ, Paesmans M, Thiriaux J, Alexopoulos CG, Baumöhl J, Schmerber J, Koumakis G, Florin MC, Zacharias C, Berghmans T, Mommen P, Ninane V, Klastersky J. Sculier JP, et al. Among authors: lafitte jj. Br J Cancer. 2000 Nov;83(9):1128-35. doi: 10.1054/bjoc.2000.1413. Br J Cancer. 2000. PMID: 11027424 Free PMC article. Clinical Trial.
Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party.
Berghmans T, Lafitte JJ, Lecomte J, Alexopoulos CG, Van Cutsem O, Giner V, Efremidis A, Berchier MC, Collon T, Meert AP, Scherpereel A, Ninane V, Leclercq N, Paesmans M, Sculier JP; European Lung Cancer Working Party. Berghmans T, et al. Among authors: lafitte jj. Br J Cancer. 2007 Jun 4;96(11):1644-9. doi: 10.1038/sj.bjc.6603772. Epub 2007 May 1. Br J Cancer. 2007. PMID: 17473825 Free PMC article. Clinical Trial.
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics.
Sculier JP, Paesmans M, Lecomte J, Van Cutsem O, Lafitte JJ, Berghmans T, Koumakis G, Florin MC, Thiriaux J, Michel J, Giner V, Berchier MC, Mommen P, Ninane V, Klastersky J; European Lung Cancer Working Party. Sculier JP, et al. Among authors: lafitte jj. Br J Cancer. 2001 Nov 16;85(10):1444-51. doi: 10.1054/bjoc.2001.2114. Br J Cancer. 2001. PMID: 11720426 Free PMC article. Clinical Trial.
Long-term survivors of small-cell lung cancer (SCLC): a French multicenter study. Groupe d'Oncologie de Langue Française.
Jacoulet P, Depierre A, Moro D, Rivière A, Milleron B, Quoix E, Ranfaing E, Anthoine D, Lafitte JJ, Lebeau B, Kleisbauer JP, Massin F, Fournel P, Zaegel M, Leclerc JP, Garnier G, Brambilla E, Capron F. Jacoulet P, et al. Among authors: lafitte jj. Ann Oncol. 1997 Oct;8(10):1009-14. doi: 10.1023/a:1008287922285. Ann Oncol. 1997. PMID: 9402175 Free article. Clinical Trial.
A phase II study testing paclitaxel as second-line single agent treatment for patients with advanced non-small cell lung cancer failing after a first-line chemotherapy.
Sculier JP, Berghmans T, Lafitte JJ, Richez M, Recloux P, Van Cutsem O, Ninane V, Mommen P, Paesmans M, Klastersky J; European Lung Cancer Working Party. Sculier JP, et al. Among authors: lafitte jj. Lung Cancer. 2002 Jul;37(1):73-7. doi: 10.1016/s0169-5002(02)00037-5. Lung Cancer. 2002. PMID: 12057870 Clinical Trial.
207 results